Jan 22 (Reuters) - Novavax Inc NVAX.O :
* NOVAVAX INC - ON JAN 19, ENTERED INTO AN ADVANCED PURCHASE AGREEMENT WITH CANADA
* NOVAVAX INC - CANADA AGREED, SUBJECT TO RECEIPT BY COMPANY OF REGULATORY APPROVAL IN CANADA, TO PURCHASE 52 MILLION DOSES OF NVX-COV2373
* NOVAVAX INC - AGREEMENT WITH CANADA INCLUDES ADDITIONAL ORDERS IT MAY MAKE FROM TIME TO TIME UP TO MAXIMUM OF 24 MILLION DOSES
* NOVAVAX - AGREED TO SUBMIT APPLICATION FOR REGULATORY APPROVAL FOR VACCINE IN CANADA AFTER FIRST SUBMISSION FOR APPROVAL IN ANOTHER PRIORITY MARKET
* NOVAVAX INC - FILED PROSPECTUS SUPPLEMENT WITH SEC WHICH CONTEMPLATES SALE OF UP TO $500 MILLION OF SHARES OF COMMON STOCK